US Patent Issued to GNT Pharma on Oct. 7 for "Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy" (South Korean, Chinese, American Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,861, issued on Oct. 7, was assigned to GNT Pharma Co. Ltd. (Yongin-si, South Korea).

"Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy" was invented by Byoung Joo Gwag (Yongin-Si, South Korea), Chun San An (Suwon-si, South Korea), Jing Yu Jin (Suwon-Si, South Korea), Sung Ig Cho (Seoul, South Korea), Fangmeng Zhu (Hangzhou Zhejiang, China), Xinliang Xu (Dongyang Zhejiang, China), Weiqiang Zhan (Alpharetta, Ga.), Fuxin Liu (Hangzhou Zhejiang, China) and Soon-Mi Won (Hwaseong-Si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to pharmaceutical compositions and ...